Requalification as a Strategic Opportunity for Sustainable Pharmaceutical Packaging

03 December 2025

Requalification is often viewed as a critical – though inconvenient – disruption in pharmaceutical operations, essential for ensuring product quality, consistency, and safety. But beyond its compliance function, this planned downtime presents a strategic opportunity to rethink packaging processes and implement innovative solutions that enhance sustainability and efficiency, explains Ian Chapman, Strategic Manager - Digital Coding at Domino Printing Sciences (Domino).

Sustainable Packaging Imperative

Pharmaceutical companies are facing mounting environmental pressure. According to American Pharmaceutical Review it is estimated that pharmaceutical manufacturing contributes roughly 52 million tonnes of CO₂ annually via packaging and operations. The implications are not only regulatory and financial; consumer and investor scrutiny is also driving change. Consumers are increasingly assessing companies’ environmental performance and approximately 70% are willing to pay more for sustainable packaging options.

Together, these factors are driving soaring demand for sustainable pharmaceutical packaging, with the market set to soar from USD 92 billion in 2024 to USD 372 billion by 2034, at a CAGR of 15%. This surge underscores that sustainability is no longer optional – it’s essential.

Eliminate Packaging Waste

The challenge for pharmaceutical manufacturing goes beyond a shift towards sustainable packaging materials: long-standing packaging practices contribute to excess waste and unused resources. The use of pre-printed materials, risk-averse stock levels, and inefficient changeovers remains widespread. Even worse, when regulators change requirements or artwork evolves, entire batches of packaging often become obsolete overnight.

Volatility within supply chains also adds to the challenge: pharma manufacturing increasingly demands agile models that support small batch sizes and late-stage customisation. Embracing inline digital printing systems lets manufacturers print on demand, eliminating stockpiles and mitigating wastage. For example, using blank foils with inline digital print not only removes the need for pre-printed stock but also reduces inventory complexity. Many manufacturers over order between 15% and 20% of pre-printed foils for each product line, resulting in significant waste – an inefficiency eradicated by blank-foil workflows.

Improve Regulatory Agility

Inline digital printing systems also support pharmaceutical manufacturers to achieve the agility demanded by constantly evolving regulations and local adaptations to support a global market. To avoid expensive and frustrating bottlenecks, pharmaceutical packaging processes must adapt swiftly, avoiding lengthy changeovers or new tooling.

Leveraging adaptable digital technology allows updates to languages, graphics, or regulatory text to be made in real time, enabling smaller batch runs, localisation, and rapid adaptation. Modern connected solutions offer cloud-enabled capabilities that can minimise downtime and accelerate time-to-market, crucial for both patient needs and regulatory demands.

Catalyst for Innovation

Requalification inevitably causes disruption. The smart approach is to treat it not as downtime, but as a strategic opportunity for continuous improvement.

Requalification is an ideal time for manufacturers to modernise with inline digital printing systems in order to align packaging with ESG goals, operational resilience, and regulatory demands. And collaboration is critical: partnering with experts who bring validated pharmaceutical technology, and a cooperative approach helps ensure scalability, accelerated ROI, and reduce risk.

Another powerful benefit is that digitalisation dramatically reduces lead times for artwork changes. Historically, approvals and printing could take weeks or months. Digital workflows, however, can compress this timeline – getting lines back up and running and revenue flowing again, much faster.

Future-Proof Packaging

Requalification doesn’t have to mean falling behind. In fact, if treated strategically, it can accelerate the transformation of pharmaceutical packaging operations into a more efficient, sustainable, and future-proof state.

The industry is moving – regulations, markets, technologies are evolving. Research from Mordor Intelligence states that the digital packaging printing market is forecast to grow from USD 34 billion in 2025 to USD 56 billion by 2030, a CAGR of over 10%. More brands are moving away from analogue prints to plate-less workflows to enable mass customisation, reduce waste, and simplify changeovers.

By taking the opportunity to upgrade technologies and workflows during the requalification window, pharmaceutical manufacturers can reduce waste, improve responsiveness, and build long-term operational resilience.

To learn how Domino can support your requalification strategy, visit our website or speak to one of our experts.

<END>

Disclaimers

Inks
The information contained in this document is not intended as a substitute for undertaking appropriate testing for your specific use and circumstances. Neither Domino UK Limited nor any of Domino’s group of companies is in any way liable for any reliance that you may put on this document with regards to the suitability of any ink for your particular application. This document does not form part of any terms and conditions between you and Domino, Legal Disclaimers v.1.0 February 2018 and Domino’s Terms and Conditions of sale, and in particular the warranties and liabilities contained within them, shall apply to any purchase of products by you.

General
Information contained within this press release is considered to be true and correct at the date of publication by Domino, changes in circumstances after the time of publication may impact the accuracy of the information. All performance related figures and claims quoted in this document were obtained under specific conditions and may only be replicated under similar conditions. For specific product details, you should contact your Domino Sales Advisor. This document does not form part of any terms and conditions between you and Domino.

Imagery
Images may include optional extras or upgrades. Print quality may differ depending on consumables, printer, substrates, and other factors. Images and photographs do not form any part of any terms and conditions between you and Domino.

Videos
This video is illustrative only and may include optional extras. Performance figures obtained under specific conditions; individual performance may vary. Errors and downtime on production lines may be unavoidable. Nothing in this video forms part of any contract between you and Domino.

Notes to Editors:

About Domino

Since 1978, Domino Printing Sciences (Domino) has established a global reputation for the development and manufacture of coding, marking, and printing technologies, as well as its worldwide aftermarket products and customer services. Today, Domino offers one of the most comprehensive portfolios of complete end-to-end coding solutions designed to satisfy the compliance and productivity requirements of manufacturers across many sectors, including food, beverage, pharmaceutical, and industrial. The company’s core technologies include innovative inkjet, laser, print and apply, and thermal transfer overprinting systems designed for the application of variable data, barcodes, and unique traceability codes onto product and packaging.

Domino employs over 3,000 people worldwide and sells to more than 120 countries through a global network of 29 subsidiary offices and more than 200 distributors. Domino’s manufacturing facilities are located in China, Germany, India, Sweden, Switzerland, UK, and the USA.
Domino became an autonomous division within Brother Industries Ltd. on 11th June 2015.

For further information on Domino, please visit www.domino-printing.com

Or contact:

Alex Challinor
PR and Content Manager
Domino Printing Sciences
Tel: +44 (0) 1954 778780
Alex.Challinor@domino-uk.com

Mahmoud Al Sabbagh
General Manager
Domino Dubai
Tel: +97148835003
Email: sales@domino-mea.com